Merck Cancidas Label Should Highlight Cyclosporine Data - FDA Committee

Labeling for Merck's antifungal Cancidas should include all available data on concomitant use with cyclosporine, although coadministration of the products is not recommended, FDA's Antiviral Drug Products Advisory Committee said Jan. 10.